Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian M M Rogasch

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2021
Reply to Paulo Schiavom DuarteJulian M M Rogasch, Carsten Kobe
PET Clinics|April 26, 2025
PET Imaging and Key Radiotracers for Evaluating Response to Locoregional Therapy in Hepatocellular CarcinomaYubei He, Julian M M Rogasch, Lynn Jeanette Savic
EJNMMI Research|November 3, 2020
Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studiesJulian M M Rogasch, Christian Furth, Stephanie Bluemel, et al.
Nuklearmedizin. Nuclear Medicine|March 15, 2018
I-123-MIBG scintigraphy in patients with neuroblastomaJulian M M Rogasch, Holger Amthauer, Christian Furth, et al.
Archives of Orthopaedic and Trauma Surgery|December 7, 2017
Degenerative changes after posterior cruciate ligament reconstruction are irrespective of posterior knee stability: MRI-based long-term resultsClemens Gwinner, Andreas Weiler, Timm Denecke, et al.
Nuklearmedizin. Nuclear Medicine|April 10, 2026
DGN procedural guideline for bone scintigraphy with SPECT and SPECT/CT in children and adolescentsJulian M M Rogasch, Holger Amthauer, Regine Kluge, et al.
Cancers|April 12, 2022
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [<sup>177</sup>Lu]Lu-DOTATOCMarkus Galler, Julian M M Rogasch, Kai Huang, et al.
BMC Cancer|May 5, 2018
Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphomaJulian M M Rogasch, Patrick Hundsdoerfer, Frank Hofheinz, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Influences on PET Quantification and InterpretationJulian M M Rogasch, Frank Hofheinz, Lutz van Heek, et al.
Clinical Nuclear Medicine|October 10, 2024
To Perform, or Not to Perform Interim PET: Questioning the Impact of Midtherapy Evaluation During PRRT in GEP-NET PatientsChristoph Wetz, Tristan Ruhwedel, Julian M M Rogasch, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2021
Reply to Paulo Schiavom DuarteJulian M M Rogasch, Carsten Kobe
PET Clinics|April 26, 2025
PET Imaging and Key Radiotracers for Evaluating Response to Locoregional Therapy in Hepatocellular CarcinomaYubei He, Julian M M Rogasch, Lynn Jeanette Savic
EJNMMI Research|November 3, 2020
Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studiesJulian M M Rogasch, Christian Furth, Stephanie Bluemel, et al.
Nuklearmedizin. Nuclear Medicine|March 15, 2018
I-123-MIBG scintigraphy in patients with neuroblastomaJulian M M Rogasch, Holger Amthauer, Christian Furth, et al.
Archives of Orthopaedic and Trauma Surgery|December 7, 2017
Degenerative changes after posterior cruciate ligament reconstruction are irrespective of posterior knee stability: MRI-based long-term resultsClemens Gwinner, Andreas Weiler, Timm Denecke, et al.
Nuklearmedizin. Nuclear Medicine|April 10, 2026
DGN procedural guideline for bone scintigraphy with SPECT and SPECT/CT in children and adolescentsJulian M M Rogasch, Holger Amthauer, Regine Kluge, et al.
Cancers|April 12, 2022
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [<sup>177</sup>Lu]Lu-DOTATOCMarkus Galler, Julian M M Rogasch, Kai Huang, et al.
BMC Cancer|May 5, 2018
Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphomaJulian M M Rogasch, Patrick Hundsdoerfer, Frank Hofheinz, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Influences on PET Quantification and InterpretationJulian M M Rogasch, Frank Hofheinz, Lutz van Heek, et al.
Clinical Nuclear Medicine|October 10, 2024
To Perform, or Not to Perform Interim PET: Questioning the Impact of Midtherapy Evaluation During PRRT in GEP-NET PatientsChristoph Wetz, Tristan Ruhwedel, Julian M M Rogasch, et al.
Pageof 5